These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35310980)

  • 1. Plasma Big Endothelin-1 Levels and Long-Term Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Front Cardiovasc Med; 2022; 9():756082. PubMed ID: 35310980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between plasma big endothelin-1 levels at admission and long-term outcomes in patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Atherosclerosis; 2018 May; 272():1-7. PubMed ID: 29529394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Platelets; 2022 Aug; 33(6):900-910. PubMed ID: 35103582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials.
    Kheiri B; Simpson TF; Osman M; Golwala H; Radaideh Q; Kumar K; Rahmouni H; Divanji P; Cigarroa JE; Zahr F
    J Thromb Thrombolysis; 2020 Nov; 50(4):867-873. PubMed ID: 32607653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia.
    Cai Z; Wang H; Yuan S; Yin D; Song W; Dou K
    Front Cardiovasc Med; 2021; 8():768431. PubMed ID: 34912865
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry.
    Miura T; Miyashita Y; Motoki H; Kobayashi H; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eizawa T; Aso S; Uchikawa S; Hashizume N; Senda K; Morita T; Ebisawa S; Izawa A; Koyama J; Ikeda U
    Cardiovasc Interv Ther; 2017 Jul; 32(3):206-215. PubMed ID: 27311986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
    De Luca L; Rubboli A; Bolognese L; Uguccioni M; Lucci D; Blengino S; Campodonico J; Meynet I; Brach Prever SM; Di Lenarda A; Gabrielli D; Gulizia MM;
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34261777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
    Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention].
    Na K; Li MY; Qiu MH; Li J; Liu R; Li Y; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Nov; 49(11):1117-1123. PubMed ID: 34775722
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention].
    Tang XF; Song Y; Xu JJ; Wang HH; Jiang L; Jiang P; Yao Y; Zhao XY; Gao Z; Yang YJ; Qiao SB; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):798-805. PubMed ID: 31648462
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Abe K; Kitahara H; Suzuki S; Hiraga T; Yamazaki T; Ohno Y; Harada J; Fukushima K; Asano T; Ishio N; Uchiyama R; Miyahara H; Okino S; Sano M; Kuriyama N; Yamamoto M; Sakamoto N; Kanda J; Kobayashi Y
    Int J Cardiol; 2024 Jun; 405():131989. PubMed ID: 38521510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Big Endothelin-1 and long-term all-cause death in patients with coronary artery disease and prediabetes or diabetes after percutaneous coronary intervention.
    Xu N; Zhu P; Yao Y; Jiang L; Jia S; Yuan D; Xu J; Wang H; Song Y; Gao L; Gao Z; Song L; Zhao X; Chen J; Yang Y; Xu B; Gao R; Yuan J
    Nutr Metab Cardiovasc Dis; 2022 Sep; 32(9):2147-2156. PubMed ID: 35843800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
    D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
    Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Tscharre M; Farhan S; Freynhofer MK; Leutner M; Baumgartner-Parzer S; Tentzeris I; Vogel B; Tinhofer F; Rohla M; Weiss TW; Huber K; Kautzky-Willer A
    Front Cardiovasc Med; 2022; 9():782602. PubMed ID: 35345492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
    Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
    Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of Free Triiodothyronine in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Yang ZQ; Ma XT; Shao QY; Li QX; Wang YF; Liang J; Shen H; Liu XL; Shi DM; Zhou YJ; Fang Z; Wang ZJ
    Rev Cardiovasc Med; 2022 Jul; 23(7):230. PubMed ID: 39076896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Farhan S; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Geppert A; Huber K; Freynhofer MK
    Eur J Clin Invest; 2019 Sep; 49(9):e13157. PubMed ID: 31318979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.